Trial Profile
Clinical Trials Insight: 700034233
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2010
Price :
$35
*
At a glance
- Drugs DE 098 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Argenes
- 05 Jun 2008 New trial record.